Company profile
UK company 13228190, incorporated on 26 February 2021.
Tabrix Developing innovative solutions to create anti-infectives for the future
Tabrix Limited is a UK company with status active founded in 2021.
Company number 13228190
Financial period: 1 Mar 2024 to 28 Feb 2025
Reference milestones and recent Companies House filing stream events.
Company registered at Companies House
TaBriX develops anti-virulence drugs for the treatment of drug-resistant infections, specialising in the treatment of TB.
Created a new company, TaBriX (https://tabrix.co.uk/) Signed collaboration agreement with Global TB Alliance Yes, have raised £102K form CCF funding and £55K from WT-P4T to test efficacy of the new compounds developed. Health benefit in an area of unmet need. New drugs to treat TB will have a world-wide health benefit, impact in society, the clinic and health system. Every year > 1.6m people die of TB and ~ 10m get infected.
Created a new company, TaBriX (https://tabrix.co.uk/) Signed collaboration agreement with Global TB Alliance Yes, have raised £102K form CCF funding and £55K from WT-P4T to test efficacy of the new compounds developed. Health benefit in an area of unmet need. New drugs to treat TB will have a world-wide health benefit, impact in society, the clinic and health system. Every year > 1.6m people die of TB and ~ 10m get infected.
Just recently registered, so the company is not yet operating.
